UGI CORP (UGI)

US9026811052 - Common Stock

24.31  -0.06 (-0.25%)

After market: 24.6 +0.29 (+1.19%)

Fundamental Rating

4

Taking everything into account, UGI scores 4 out of 10 in our fundamental rating. UGI was compared to 13 industry peers in the Gas Utilities industry. UGI has an average financial health and profitability rating. UGI has a valuation in line with the averages, but it does not seem to be growing. UGI also has an excellent dividend rating.



4

1. Profitability

1.1 Basic Checks

In the past year UGI was profitable.
In the past year UGI had a positive cash flow from operations.
UGI had positive earnings in 4 of the past 5 years.
In the past 5 years UGI always reported a positive cash flow from operatings.

1.2 Ratios

UGI has a Return On Assets of 4.47%. This is in the better half of the industry: UGI outperforms 76.92% of its industry peers.
UGI's Return On Equity of 14.38% is fine compared to the rest of the industry. UGI outperforms 76.92% of its industry peers.
UGI's Return On Invested Capital of 7.68% is fine compared to the rest of the industry. UGI outperforms 76.92% of its industry peers.
Industry RankSector Rank
ROA 4.47%
ROE 14.38%
ROIC 7.68%
ROA(3y)1.71%
ROA(5y)2.17%
ROE(3y)3.34%
ROE(5y)5.92%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

UGI has a Profit Margin (9.13%) which is comparable to the rest of the industry.
UGI has a Operating Margin (18.19%) which is comparable to the rest of the industry.
UGI's Gross Margin of 52.08% is on the low side compared to the rest of the industry. UGI is outperformed by 76.92% of its industry peers.
UGI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 18.19%
PM (TTM) 9.13%
GM 52.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-24.35%
GM growth 5Y-13.19%

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UGI is creating some value.
The number of shares outstanding for UGI has been reduced compared to 1 year ago.
The number of shares outstanding for UGI has been increased compared to 5 years ago.
Compared to 1 year ago, UGI has a worse debt to assets ratio.

2.2 Solvency

UGI has an Altman-Z score of 1.38. This is a bad value and indicates that UGI is not financially healthy and even has some risk of bankruptcy.
UGI has a Altman-Z score of 1.38. This is amongst the best in the industry. UGI outperforms 84.62% of its industry peers.
UGI has a debt to FCF ratio of 15.48. This is a negative value and a sign of low solvency as UGI would need 15.48 years to pay back of all of its debts.
UGI has a better Debt to FCF ratio (15.48) than 76.92% of its industry peers.
A Debt/Equity ratio of 1.42 is on the high side and indicates that UGI has dependencies on debt financing.
The Debt to Equity ratio of UGI (1.42) is worse than 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF 15.48
Altman-Z 1.38
ROIC/WACC1.3
WACC5.9%

2.3 Liquidity

UGI has a Current Ratio of 0.91. This is a bad value and indicates that UGI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of UGI (0.91) is better than 84.62% of its industry peers.
A Quick Ratio of 0.71 indicates that UGI may have some problems paying its short term obligations.
With an excellent Quick ratio value of 0.71, UGI belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.71

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.60% over the past year.
UGI shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.79% yearly.
The Revenue for UGI has decreased by -22.06% in the past year. This is quite bad
Measured over the past years, UGI shows a small growth in Revenue. The Revenue has been growing by 3.14% on average per year.
EPS 1Y (TTM)15.6%
EPS 3Y2.2%
EPS 5Y0.79%
EPS Q2Q%93.94%
Revenue 1Y (TTM)-22.06%
Revenue growth 3Y10.83%
Revenue growth 5Y3.14%
Sales Q2Q%-16.82%

3.2 Future

UGI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.29% yearly.
UGI is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.82% yearly.
EPS Next Y3.95%
EPS Next 2Y3.11%
EPS Next 3Y2.29%
EPS Next 5Y2.29%
Revenue Next Year-11.46%
Revenue Next 2Y-1.27%
Revenue Next 3Y-0.46%
Revenue Next 5Y-0.82%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.46, which indicates a rather cheap valuation of UGI.
UGI's Price/Earnings ratio is rather cheap when compared to the industry. UGI is cheaper than 92.31% of the companies in the same industry.
When comparing the Price/Earnings ratio of UGI to the average of the S&P500 Index (28.65), we can say UGI is valued rather cheaply.
A Price/Forward Earnings ratio of 8.02 indicates a reasonable valuation of UGI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UGI indicates a rather cheap valuation: UGI is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.56, UGI is valued rather cheaply.
Industry RankSector Rank
PE 7.46
Fwd PE 8.02

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, UGI is valued cheaply inside the industry as 92.31% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, UGI is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.68
EV/EBITDA 6.14

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)1.89
PEG (5Y)9.44
EPS Next 2Y3.11%
EPS Next 3Y2.29%

8

5. Dividend

5.1 Amount

UGI has a Yearly Dividend Yield of 6.45%, which is a nice return.
UGI's Dividend Yield is rather good when compared to the industry average which is at 4.22. UGI pays more dividend than 92.31% of the companies in the same industry.
UGI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.23.
Industry RankSector Rank
Dividend Yield 6.45%

5.2 History

On average, the dividend of UGI grows each year by 7.59%, which is quite nice.
UGI has been paying a dividend for at least 10 years, so it has a reliable track record.
UGI has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)7.59%
Div Incr Years33
Div Non Decr Years33

5.3 Sustainability

46.95% of the earnings are spent on dividend by UGI. This is a bit on the high side, but may be sustainable.
UGI's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP46.95%
EPS Next 2Y3.11%
EPS Next 3Y2.29%

UGI CORP

NYSE:UGI (11/20/2024, 8:04:00 PM)

After market: 24.6 +0.29 (+1.19%)

24.31

-0.06 (-0.25%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryGas Utilities
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.22B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 6.45%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 7.46
Fwd PE 8.02
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.89
PEG (5Y)9.44
Profitability
Industry RankSector Rank
ROA 4.47%
ROE 14.38%
ROCE
ROIC
ROICexc
ROICexgc
OM 18.19%
PM (TTM) 9.13%
GM 52.08%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.91
Quick Ratio 0.71
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)15.6%
EPS 3Y2.2%
EPS 5Y
EPS Q2Q%
EPS Next Y3.95%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-22.06%
Revenue growth 3Y10.83%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y